Russell Investments Group
SGMT icon

Russell Investments Group’s Sagimet Biosciences SGMT Stock Holding History

Russell Investments Group’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.3K Buy
+4,699
New +$32K ﹤0.01% 3692
2024
Q3 		– Sell
-1,197
Closed -$4.09K – 3784
2024
Q2 		$4.09K Buy
1,197
+186
+18% +$853 ﹤0.01% 3259
2024
Q1 		$5.48K Buy
+1,011
New +$7.26K ﹤0.01% 2931

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Russell Investments Group's SGMT Position: Q2 2026 in Review

Russell Investments Group opened a new position in Sagimet Biosciences (SGMT) in Q2 2026: 4,699 shares worth $36.3K. The stake represents ﹤0.01% of the portfolio and ranks #3692 among its holdings. This is a return to the name: Russell Investments Group previously reported a position in SGMT as recently as Q2 2024.

Russell Investments Group first reported a position in SGMT in Q1 2024 and has held it in 3 quarters since. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Russell Investments Group held 4,699 shares of Sagimet Biosciences worth $36.3K as of Q2 2026.
  • Sagimet Biosciences was a new Russell Investments Group position in Q2 2026.
  • Sagimet Biosciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3692 holding.
  • Russell Investments Group first reported a position in Sagimet Biosciences in Q1 2024 and has held it in 3 quarters since.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.